Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Slotman

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Practical Radiation Oncology|April 25, 2025
Partial Breast Radiation Therapy in Low-Risk Breast Cancer Using a Magnetic Resonance Imaging-Guided Adaptive Approach; Results of the Phase 2 PARLOB StudyC van Vliet, S Tetar, H J G D van den Bongard, et al.
British Journal of Cancer|February 6, 2003
Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cellsJ van Rijn, J van den Berg, T Teerlink, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung CancerM I Ronden, J R van Sörnsen de Koste, C Johnson, et al.
Frontiers in Oncology|June 16, 2023
Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohortD Doppenberg, F J Lagerwaard, S van Dieren, et al.
British Journal of Cancer|June 3, 2010
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomideK A van Nifterik, J van den Berg, W F van der Meide, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancerS M de Lange, C J van Groeningen, O W M Meijer, et al.
Neurology|July 10, 2002
Radiotherapy-induced cerebral abnormalities in patients with low-grade gliomaT J Postma, M Klein, C C P Verstappen, et al.
Journal of Neurology|February 20, 2008
Radiosurgery of brain arteriovenous malformations in childrenD R Buis, C M F Dirven, F J Lagerwaard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2026
The Relevance of Cancer-Type-Specific Scenarios in Predicting Primary Radiotherapy Use in Nonmetastatic Cancer Patients in the Netherlands Towards 2032H Struikmans, J Evers, J W Bauhuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysisN E Verstegen, J W A Oosterhuis, D A Palma, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Practical Radiation Oncology|April 25, 2025
Partial Breast Radiation Therapy in Low-Risk Breast Cancer Using a Magnetic Resonance Imaging-Guided Adaptive Approach; Results of the Phase 2 PARLOB StudyC van Vliet, S Tetar, H J G D van den Bongard, et al.
British Journal of Cancer|February 6, 2003
Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cellsJ van Rijn, J van den Berg, T Teerlink, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung CancerM I Ronden, J R van Sörnsen de Koste, C Johnson, et al.
Frontiers in Oncology|June 16, 2023
Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohortD Doppenberg, F J Lagerwaard, S van Dieren, et al.
British Journal of Cancer|June 3, 2010
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomideK A van Nifterik, J van den Berg, W F van der Meide, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancerS M de Lange, C J van Groeningen, O W M Meijer, et al.
Neurology|July 10, 2002
Radiotherapy-induced cerebral abnormalities in patients with low-grade gliomaT J Postma, M Klein, C C P Verstappen, et al.
Journal of Neurology|February 20, 2008
Radiosurgery of brain arteriovenous malformations in childrenD R Buis, C M F Dirven, F J Lagerwaard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2026
The Relevance of Cancer-Type-Specific Scenarios in Predicting Primary Radiotherapy Use in Nonmetastatic Cancer Patients in the Netherlands Towards 2032H Struikmans, J Evers, J W Bauhuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysisN E Verstegen, J W A Oosterhuis, D A Palma, et al.
Pageof 9